Persistent Gaps in Semaglutide and Tirzepatide Prescribing Among Adults With Class III Obesity Without Type 2 Diabetes

Diabetes, obesity & metabolism · 2026 Nov 9 · Kang B, Choi K, Yang H et

By Maren Holt · Senior Reporter, GLP-1

Nov 8 19:00 ETSource: Diabetes, obesity & metabolism

From the source

Persistent Gaps in Semaglutide and Tirzepatide Prescribing Among Adults With Class III Obesity Without Type 2 Diabetes
Diabetes, obesity & metabolism · 2026 Nov 9 · Kang B, Choi K, Yang H et al.

Read at pubmed.ncbi.nlm.nih.gov

Source URL https://pubmed.ncbi.nlm.nih.gov/43003413/